Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2012
10/25/2012US20120269835 Process for the production of immunogenic compositions
10/25/2012US20120269834 Immunoglobulin cleavage fragment vaccine compositions
10/25/2012US20120269833 Allorestricted peptide-specific t cells
10/25/2012US20120269831 Substituted pyrido[2,3-d]pyrimidin-7(8h)-ones and therapeutic uses thereof
10/25/2012US20120269830 Conjugates with improved pharmacokinetic properties
10/25/2012US20120269829 Inhibitors of Phosphatase and Tensin Homolog (PTEN) Compositions, Uses and Methods
10/25/2012US20120269828 Anti-drug vaccines
10/25/2012US20120269827 Compositions and Methods for Treatment of Ovarian, Peritoneal, and Fallopian Tube Cancer
10/25/2012US20120269826 Anti-cd3 antibody dosing in autoimmune disease
10/25/2012US20120269825 Methods of modulating the ox40 receptor to treat cancer
10/25/2012US20120269824 Therapeutic human anti-il-1r1 monoclonal antibody
10/25/2012US20120269823 Virulent isolate of neospora caninum and its uses
10/25/2012US20120269822 Anti-Botulinum Neurotoxin a Single Domain Antibody Antibodies
10/25/2012US20120269821 Hiv-1 antibodies
10/25/2012US20120269820 Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof
10/25/2012US20120269819 Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors
10/25/2012US20120269818 Methods for treating infection by hpv
10/25/2012US20120269817 Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor
10/25/2012US20120269816 Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor-I
10/25/2012US20120269815 Neurotrophins and uses thereof
10/25/2012US20120269814 Anti-c mpl antibodies
10/25/2012US20120269813 Polyclonal bispecific antibody compositions and method of use
10/25/2012US20120269812 Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies
10/25/2012US20120269811 Humanized fc gamma riib-specific antibodies and methods of use thereof
10/25/2012US20120269810 Methods and compositions for panic disorders
10/25/2012US20120269809 TNFalpha-Neutralizing Antibodies
10/25/2012US20120269808 Methods and compositions for modulating tweak and fn14 activity
10/25/2012US20120269807 COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY OF lgG-DECOY RECEPTOR FUSION PROTEINS
10/25/2012US20120269806 Methods of inducing tolerance
10/25/2012US20120269805 Antibodies directed against amyloid-beta peptide and methods using same
10/25/2012US20120269804 Substituted benzosulphonamides
10/25/2012US20120269803 Substituted benzosulphonamides
10/25/2012US20120269802 Treatment And Prognosis With Thalidomide In Multiple Myeloma Based on Karyotyping And Gene Expression Profiling
10/25/2012US20120269801 Methods and compositions for the treatment of proliferative and pathogenic diseases
10/25/2012US20120269800 Anti-neoplastic compositions comprising extracts of black cohosh
10/25/2012US20120269799 Diagnostic and treatment methods using a ligand library
10/25/2012US20120269798 Enhancement of regeneration by modulation of notum activity
10/25/2012US20120269797 Method for inhibiting the maturation of dendritic cells
10/25/2012US20120269766 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
10/25/2012US20120269765 Cytokine compositions and methods of use thereof
10/25/2012US20120269762 Causal therapy of diseases or conditions associated with cns or pns demyelination
10/25/2012US20120269726 Heterodimers of Glutamic Acid
10/25/2012US20120269723 Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent
10/25/2012DE102011018499A1 Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut Topical nanoparticle vaccines for immune stimulation of the dendritic cells in the skin
10/24/2012EP2514828A2 Methods for the production of ansamitocins
10/24/2012EP2514824A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
10/24/2012EP2514823A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
10/24/2012EP2514768A1 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant
10/24/2012EP2514766A2 Antibodies, methods and kits for diagnosing and treating melanoma
10/24/2012EP2514765A1 Gpr177 as target and marker in tumors
10/24/2012EP2514764A2 Antibody molecules which bind IL-17A and IL-17F
10/24/2012EP2514763A1 Egf receptor epitope peptides and uses thereof
10/24/2012EP2514439A1 Anti-TSG101antibodies and their uses for treatment of viral infections
10/24/2012EP2514438A1 ADJUVANT CONTAINING ß-HEMATIN
10/24/2012EP2514437A1 Frozen stockpiling of influenza vaccines
10/24/2012EP2513144A1 Methods of treating interstitial cystitis
10/24/2012EP2512600A2 Wise binding agents and epitopes
10/24/2012EP2512512A1 Uniform field magnetization and targeting of therapeutic formulations
10/24/2012EP2512511A1 Humanized antibodies against human il-22ra
10/24/2012EP2512510A1 A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy
10/24/2012EP2512509A2 Injection needle and device
10/24/2012EP2512508A1 Novel influenza virus
10/24/2012EP2512507A1 Treatment of nasal and sinus disorders
10/24/2012EP2512506A2 Parasite vaccine
10/24/2012CN102753683A Protein having cedar pollen immunogenicity, polynucleotide for coding for said protein, and uses of said protein and polynucleotide
10/24/2012CN102753582A Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps
10/24/2012CN102753581A Antl-igf-ir antibodies and uses thereof
10/24/2012CN102753579A Anti-cadherin antibody
10/24/2012CN102753578A Compositions and methods for increasing muscle growth
10/24/2012CN102753577A Bispecific anti-vegf/anti-ang-2 antibodies
10/24/2012CN102753567A Mybl2 peptides and vaccines containing the same
10/24/2012CN102753199A Cancer stem cell markers and uses thereof
10/24/2012CN102753197A Immunoglobulin preparation
10/24/2012CN102753195A Methods for enhancing anti-tumor antibody therapy
10/24/2012CN102753194A J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
10/24/2012CN102753193A Light targeting molecules and uses thereof
10/24/2012CN102753191A Treatment and prevention of cancers associated with intracellular oncoproteins by antibody therapy or vaccination
10/24/2012CN102753149A Circulation of components during homogenization /microfluidisation of emulsions
10/24/2012CN102747103A AIDS vaccine of double-deletion replicative vaccinia virus based on A52L gene and B8R gene
10/24/2012CN102747096A Gene search vector, random gene mutation control method and application thereof
10/24/2012CN102747092A Recombinant defective adenoviruses expressing O type foot and mouth disease virus empty capsid, and applications thereof
10/24/2012CN102747048A Mycobacterium tuberculosis candidate antigen and its application
10/24/2012CN102747047A Human papillomaviruse type hybrid virus-like particles and preparation method thereof
10/24/2012CN102747045A Swine influenza virus H1N1 SIVTJ inactivated vaccine and preparation method thereof
10/24/2012CN102747039A Tumor-associated antigen, monoclonal antibody and purpose thereof
10/24/2012CN102747024A EHEC 0157:H7 multivalent fliC-hcpA-tir-eae recombinant strain and vaccine
10/24/2012CN102746414A Sedimentation method of lipopolysaccharides
10/24/2012CN102746402A Fully-humanized anti-human prolactin receptor single-chain antibody and application thereof
10/24/2012CN102746401A Polypeptide compound for inhibiting angiogenesis and tumor growth
10/24/2012CN102746400A Antibodies against human angiopoietin 2
10/24/2012CN102746399A Anti-Ngf Antibodies And Methods Using Same
10/24/2012CN102746398A Single-chain antibody ZL1 against chicken-derived Newcastle disease virus P protein, preparation method and application thereof
10/24/2012CN102746397A Single-chain antibody ZL2 against chicken-derived Newcastle disease virus P protein, preparation method and application thereof
10/24/2012CN102746389A Streptococcus adhesion antigen GAPDH and preparation method thereof
10/24/2012CN102746388A Streptococcus protective antigen C5a and preparation method thereof
10/24/2012CN102746387A DNA (Deoxyribose Nucleic Acid) vaccine of HCV (Hepatitis C Virus) and preparation method thereof
10/24/2012CN102746381A Helicobacter pylori antigen HLA restrictive immunodominance epitope peptide and preparation method and application thereof
10/24/2012CN102746377A Epitope peptide of mycobacterium trberculosis protein antigen, and its application
10/24/2012CN102743762A Receptor-mediated quantum dot tracing targeted drug delivery system, preparation method thereof and application
10/24/2012CN102743761A System purification, detection and treatment
1 ... 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 ... 1823